Skip to content

Retrospective Study of Airway Management in Dutch ED's

A Retrospective Study on the Practice and Safety of Airway Management in Dutch Emergency Departments

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06374030
Enrollment
1000
Registered
2024-04-18
Start date
2019-01-01
Completion date
2024-12-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endotracheal Intubation

Brief summary

Describing characteristics of the practice of airway management in Dutch emergency departments, including information about patient demographics, indications, performer characteristics, equipment and medication used and complications due to intubation.

Detailed description

Endotracheal intubation can be a lifesaving intervention for critically ill patients in the emergency department (ED). Endotracheal intubation is, however, a high-risk procedure with many potential complications, which seem to be even more prevalent when carried out in the ED compared to for example the operating theater. This is possibly due to multiple reasons such as a sicker population, non-elective setting, a higher variability among indications for intubation or competence of providers. Internationally, large registries were established and multiple observational studies have been performed to gain more information about the methods, safety and complications of intubations in the ED. While in recent years these studies have added to our knowledge of ED airway management, there is still a lack of high-quality studies and there is a strong argument for increased research. To date, no studies have been published of airway management in Dutch EDs. The investigators therefore have no knowledge about any factors possibly influencing intubation outcomes and complications nor comparability with international data. Among these are factors that have been associated with preventable harm and death and insight into these factors could be used for improvement of the safety of airway management in Dutch EDs. This study is therefore intended to provide a comprehensive review of the clinical practice and characteristics of endotracheal intubations within Dutch EDs. The results could potentially be used for comparative analysis against global datasets. Additionally, the insights gained from this study will shed light on existing gaps prevalent in the current registration processes of intubations in the Netherlands. Furthermore, these insights could act as a stepping stone for future investigations that can lead to a deeper understanding of the methodologies, safety protocols, and associated complications of endotracheal intubations within Dutch EDs

Interventions

PROCEDUREEndotracheal intubation

All endotracheal intubations carried out in the emergency department of one of the participating hospitals in the time period 01-01-2019 - 31-12-2023

Sponsors

VieCuri Medical Centre
CollaboratorOTHER
Catharina Ziekenhuis Eindhoven
CollaboratorOTHER
Rijnstate Hospital
CollaboratorOTHER
Zuyderland Medical Centre
CollaboratorOTHER
Frisius Medisch Centrum
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's

Exclusion criteria

* Patients for which no information about the intubation can be found in the electronic patient chart will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Different complications of endotracheal intubationAt the time of intervention and consequent 1 hour* significant decrease of SpO2. Defined as: desaturation of \>10% from baseline or as defined by the treating physician * significant decrease of blood pressure. Defined as: systolic pressure \<90mmHg with a drop of \>20% from baseline or as defined by the treating physician. * significant increase of blood pressure. Defined as: systolic pressure \> 160mmHg with a rise of \>20% from baseline, or as defined by the treating physician. * significant bradycardia. Defined as: heart rate \< 40/min and a drop of \> 20% from baseline, or as defined by the treating physician. * significant tachycardia. Defined as: heart rate \> 160/min and a rise of \> 20% from baseline, or as defined by the treating physician. * dental or airway trauma * oesophageal or mainstem bronchial intubation * vomiting or aspiration * laryngospasm * equipment failure * medication error * cardiac arrest * failed attempt / need for an emergency surgical airway * other

Other

MeasureTime frameDescription
Indication for intubationAt the time of intervention and consequent 1 hourIndications could be: Trauma Burns Drowning Overdose/ingestion Respiratory failure Cardiac arrest (active cardiac arrest) Post-cardiac arrest Stroke Seizure Altered mental status due to other cause (if altered mental status due to stroke, intoxication, seizure or post-cardiac arrest then score as the primary cause) Sepsis Cardiac failure Airway obstruction GI bleed Anaphylaxis Other
Sedation agent usedAt the time of intervention and consequent 1 hourKetamine, etomidate, propofol, midazolam
Paralytic agent usedAt the time of intervention and consequent 1 hourRocuronium / Succinylcholine
Intubator characteristicsAt the time of intervention and consequent 1 hourSpecialty and function/seniority of the intubator
Method of intubationAt the time of intervention and consequent 1 hourDirect laryngoscopy Video (hyperangulated or direct) Fiberoptic Surgical airway
Patient characteristicsAt the time of intervention and consequent 1 hourDemographics of the patient who underwent endotracheal intubation. Such as age (years), gender (male/female), weight/obesity (BMI)
Sedative agent after intubationAt the time of intervention and consequent 1 hourPropofol Fentanyl Midazolam Morphine Ketamine Other Not indicated

Countries

Netherlands

Contacts

Primary ContactPeter Veldhuis, MD
peter.veldhuis@mcl.nl+3158 286 6666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 24, 2026